Previous close | 3.0400 |
Open | 3.1000 |
Bid | 2.9100 x 38500 |
Ask | 2.9500 x 1400 |
Day's range | 2.7800 - 3.1000 |
52-week range | 2.2000 - 10.6400 |
Volume | |
Avg. volume | 7,363,606 |
Market cap | 664.515M |
Beta (5Y monthly) | 3.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | -4.7510 |
Earnings date | 12 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.29 |
No matter your level of experience investing money on Wall Street, it's been a rough year. Meanwhile, the technology-driven Nasdaq Composite declined close to 30% from its November all-time high, firmly placing it in a bear market. This is why Wall Street analysts typically have a bullish outlook on many of the companies they cover.
Canadian cannabis company Aurora Cannabis (NASDAQ: ACB) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (NASDAQ: CGC) and Sundial Growers (NASDAQ: SNDL) are benefiting as well -- up 8.5% and 5.9%, respectively. Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.
With me today are CEO, Miguel Martin; and CFO, Glen Ibbott. Listeners are also reminded that certain matters discussed in today's conference call could constitute forward-looking statements that are subject to risks and uncertainties related to our future financial or business performance.